What we have achieved
We delivered a new treatment that is equal to the best hepatitis C drugs, at a fraction of the cost.
An affordable cure to leave no one behind. We have developed a new simple-to-use, affordable treatment for hepatitis C to increase access and minimize financial burden on patients and health systems. Trial results in Malaysia showed 97% of people treated were cured.
What we are doing for people living with hepatitis C
We are now working to help foster an enabling environment for improved availability of hepatitis C diagnostics and treatments in low- and middle-income countries and supporting innovative ‘test-and-treat’ programmes in several countries.
Building capacity, uniting expertise
Research platforms and consortiums that bring together researchers and strengthen research capacities in low- and middle-income countries are central to our virtual R&D model.
Partnering for patients
Collaboration is an essential part of how we work. We have forged a diverse range of alliances and research collaborations with over 200 partners in nearly 50 countries.
Making medical history for neglected patients
We develop urgently needed treatments for neglected patients and ensure they’re affordable, available, and adapted to the communities who need them
Stay connected
Get our latest news, personal stories, research articles, and job opportunities.
Get in touch
Support us
Work with us
-
Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License